Trial NCT00330668

View at ClinicalTrials.gov 
Org. Study IDs: MS306
Secondary IDs: 2019-000844-81

Last trial update was posted on 2020-08-14

MeSH Interventions

Mecasermin

MeSH Conditions

Failure to Thrive Growth Disorders

Other Conditions


Stopping Reasons

Unacceptable frequency of hypoglycemia observed at and above 200 ug/kg/day

Limitations And Caveats

The study was terminated by the sponsor due to an unacceptably high incidence of hypoglycaemia observed in approximately 50% of the subjects receiving 200 μg/kg rhIGF-1 or greater QD.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID